Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Titel:
Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation
Auteur:
Liu, Ta-Ming Woyach, Jennifer A. Zhong, Yiming Lozanski, Arletta Lozanski, Gerard Dong, Shuai Strattan, Ethan Lehman, Amy Zhang, Xiaoli Jones, Jeffrey A. Flynn, Joseph Andritsos, Leslie A. Maddocks, Kami Jaglowski, Samantha M. Blum, Kristie A. Byrd, John C. Dubovsky, Jason A. Johnson, Amy J.